Loading articles...
Peptide-Based Preparations May Invert Colonoscopy Risk Profile
Novel peptide-based preparations for colonoscopy may mitigate the risks associated with inadequate bowel cleansing, potentially inverting the traditional risk-benefit profile.
MRI Predicts Rectal Cancer Survival Better Than Pathology
New research indicates MRI-based features and AI models may offer superior prognostic value in rectal cancer compared to traditional pathology.
AI System Achieves >90% Accuracy in Colonoscopy Surveillance
An AI system demonstrated over 90% accuracy in selecting appropriate colonoscopy surveillance intervals, potentially reducing unnecessary procedures.
Pesticide Exposure Linked to Early-Onset Colorectal Cancer Risk
A common pesticide, permethrin, has been associated with an increased risk of early-onset colorectal cancer, prompting questions about environmental factors in disease etiology.
CMS Adopts Performance-Based Standards for CRC Biomarker Tests
The Centers for Medicare & Medicaid Services (CMS) has implemented new performance-based standards for colorectal cancer (CRC) biomarker tests, despite ongoing questions regarding the clinical utility of some assays.
ctDNA Liquid Biopsy in Colorectal Cancer: Where the Evidence Sits Now
Three 2026 reviews map the current evidence for ctDNA and liquid biopsy in CRC detection and monitoring, and where integration lags behind the data.